Inhibition of Dipeptidyl Peptidase IV by Fluoroolefin-containing N-peptidyl-O-hydroxylamine Peptidomimetics

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Nov 25

PMID 9826645

Citations 1

Authors

J Lin

P J Toscano

J T Welch

Affiliations

Soon will be listed here.

Abstract

Dipeptidyl peptidase IV (EC 3.4.14.5; DPP IV), also known as the leukocyte differentiation antigen CD26 when found as an extracellular membrane-bound proline specific serine protease, cleaves a dipeptide from the N terminus of a polypeptide chain containing a proline residue in the penultimate position. Here we report that known (Z)-Ala-psi[CF=C]-Pro dipeptide isosteres 1 and 2, which contain O-acylhydroxylamines, were isolated as diastereomeric pairs u-1, l-1, and l-2. The effect of each diastereomeric pair as an inhibitor of human placental dipeptidyl peptidase DPP IV has been examined. The inhibition of DPP IV by these compounds is rapid and efficient. The diastereomeric pair u-1 exhibits very potent inhibitory activity with a Ki of 188 nM. Fluoroolefin containing N-peptidyl-O-hydroxylamine peptidomimetics, by virtue of their inhibitory potency and stability, are superior to N-peptidyl-O-hydroxylamine inhibitors derived from an Ala-Pro dipeptide.

Citing Articles

Stereoselective synthesis of geminal bromofluoroalkenes by kinetically controlled selective conversion of oxaphosphetane intermediates.

Jin J, Song S, Choi J, Chung W Sci Adv. 2024; 10(44):eadq5316.

PMID: 39475612 PMC: 11804150. DOI: 10.1126/sciadv.adq5316.

The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism.

Engel M, Hoffmann T, Wagner L, Wermann M, Heiser U, Kiefersauer R Proc Natl Acad Sci U S A. 2003; 100(9):5063-8.

PMID: 12690074 PMC: 154298. DOI: 10.1073/pnas.0230620100.

References

Gruber M, Scholz W, Flad H . Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen. Cell Immunol. 1988; 113(2):423-34. DOI: 10.1016/0008-8749(88)90039-1. View

Lambeir A, Borloo M, De Meester I, Belyaev A, Augustyns K, Hendriks D . Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV. Biochim Biophys Acta. 1996; 1290(1):76-82. DOI: 10.1016/0304-4165(96)00012-8. View

Feller A, Heijnen C, Ballieux R, Parwaresch M . Enzymehistochemical staining of T mu lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV). Br J Haematol. 1982; 51(2):227-34. View

Fischer G, Heins J, Barth A . The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases. Biochim Biophys Acta. 1983; 742(3):452-62. DOI: 10.1016/0167-4838(83)90261-3. View

Bachovchin W, Plaut A, Flentke G, Lynch M, Kettner C . Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids. J Biol Chem. 1990; 265(7):3738-43. View

Ulmer A, Mattern T, Feller A, HEYMANN E, Flad H . CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand J Immunol. 1990; 31(4):429-35. DOI: 10.1111/j.1365-3083.1990.tb02789.x. View

Ansorge S, Buhling F, Kahne T, Lendeckel U, Reinhold D, Tager M . CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. Adv Exp Med Biol. 1997; 421:127-40. DOI: 10.1007/978-1-4757-9613-1_17. View

Frohman L, Downs T, Williams T, Heimer E, Pan Y, Felix A . Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest. 1986; 78(4):906-13. PMC: 423714. DOI: 10.1172/JCI112679. View

Proost P, De Meester I, Schols D, Struyf S, Lambeir A, Wuyts A . Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem. 1998; 273(13):7222-7. DOI: 10.1074/jbc.273.13.7222. View

10.

Oravecz T, Roderiquez G, Koffi J, Wang J, Ditto M, Lusso P . CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat Med. 1995; 1(9):919-26. DOI: 10.1038/nm0995-919. View

11.

Dalgleish A . HIV and CD26. Nat Med. 1995; 1(9):881-2. DOI: 10.1038/nm0995-881. View

12.

Cieplak P, Kollman P . Peptide mimetics as enzyme inhibitors: use of free energy perturbation calculations to evaluate isosteric replacement for amide bonds in a potent HIV protease inhibitor. J Comput Aided Mol Des. 1993; 7(3):291-304. DOI: 10.1007/BF00125504. View

13.

Dang N, Torimoto Y, Sugita K, Daley J, Schow P, Prado C . Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol. 1990; 145(12):3963-71. View

14.

Schon E, Demuth H, Barth A, Ansorge S . Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochem J. 1984; 223(1):255-8. PMC: 1144287. DOI: 10.1042/bj2230255. View

15.

Reinhold D, Wrenger S, Bank U, Buhling F, Hoffmann T, Neubert K . CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells. Immunobiology. 1996; 195(1):119-28. DOI: 10.1016/s0171-2985(96)80010-6. View

16.

Hanski C, Huhle T, REUTTER W . Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol Chem Hoppe Seyler. 1985; 366(12):1169-76. DOI: 10.1515/bchm3.1985.366.2.1169. View

17.

Dong R, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman S . Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol. 1996; 156(4):1349-55. View

18.

Demuth H, Baumgrass R, Schaper C, Fischer G, Barth A . Dipeptidylpeptidase IV--inactivation with N-peptidyl-O-aroyl hydroxylamines. J Enzyme Inhib. 1988; 2(2):129-42. DOI: 10.3109/14756368809040718. View

19.

Frohman L, Downs T, Heimer E, Felix A . Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest. 1989; 83(5):1533-40. PMC: 303858. DOI: 10.1172/JCI114049. View

20.

Torimoto Y, Dang N, Vivier E, Tanaka T, Schlossman S, Morimoto C . Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol. 1991; 147(8):2514-7. View